Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject +/- EPO for Preoperative Anaemia in Orthopaedic Surgery
NCT00706667Phase 4Terminated
- Sponsor
- University of Zurich
- Start
- May 2008
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by University of Zurich. Started May 2008; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT00706667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00706667.